WHICH ONE WOULD YOU CHOOSE?
It all started around march 2020 here in India, when we all
were suddenly disrupted from our daily lives. At that time, we all were praying
for some miracle to happen in the pharmaceutical industry, to get a vaccine out
of sky, as soon as possible. The irony is now, after a year when the various
vaccine candidates have finally arrived, they all started to compete with each
other, then to compete with the pandemic itself.
So basically, this blog is to tell the differences between
the various vaccines available or might be available. Because apparently, there
is a lot of fuss going around for what to consider for our lives and what not
to.
In the case of a classical vaccine, like the present ones
such as for polio, influenza, rabies. A weaker version of the same virus is
being used inside the vaccine, which goes inside the body, and produces an
immune response in the form of antibodies. An example for this type of COVID-19
vaccine is of the covaxin(India).
In the case of vaccines used for covid19, most of them have some sort of genetic modification. The two major vaccines in the world, Pfizer and moderna have used the m-RNA based vaccine. This type of vaccine doesn’t use the normal virus, instead they just use the genetic code of the same virus or to be specific a part of the virus. The m-RNA vaccines are the vaccines of the new world which can be produced with in large numbers since it doesn’t require the original virus. Thus, the production rate is quite high. Covid-19 is the first m-RNA vaccine which has been approved. So how does this covid19 vaccine works?
·
At first the m-RNA of the spike protein (part of
virus) is genetically modified so that it doesn’t cause any harm to the human
body. (In simple terms, m-RNA is the information to make a protein).
·
Secondly, this m-RNA is packed into lipid nano
particles to get inside the body.
·
After
being injected into the upper arm, this information is being used by the muscle
cells to produce spike proteins. So now our body gets to know that something
different is there and starts producing antibodies against the same covid19
virus and starts an immune response so that the next when the same virus comes, our body will be able to identify it.
Talking about the other one, from the researchers of oxford and being produced here in India, the AstraZeneca. Adenoviruses are the most preferable and easily used for gene delivery, so they have used an adenovirus which causes common cold in chimpanzees (harmless to humans), genetically modified it with coronavirus spike proteins and used as a vaccine. This genetically modified adenovirus delivers the gene to human cells and then the whole process is same as the RNA one.
This vaccine candidate
is quite a good choice for the developing nations, the reason being its storage
temperature viz. about 2-8 degree Celsius. On contrary, the Pfizer and moderna
has the storage temperatures of about -20 to -80 degree Celsius. So, considering
such values, getting a proper logistics and supply chain is not a choice for
some nations around the globe.
Which
vaccine is more efficient?
In pharmaceutical world a vaccine efficacy is defined as the percentage reduction of disease in a
vaccinated group of people compared to an unvaccinated group(placebo). The
various groups have already published their efficacy data on the questioned
vaccine, but some have not.
As an undergraduate student I
am in nowhere to question the efficacy data and the hard work of researchers. But
the matter of fact which concerns me that some of the approved vaccines haven’t
really completed their trails or not even given a proper efficacy data, which
itself is a big concern. I am just providing a comparison to judge on your own.
|
|
Pfizer/BioNTech |
Moderna |
Oxford/Astrazeneca/Covishield |
Covaxin |
|
TYPE |
m-RNA |
m-RNA |
Genetically modified adenovirus. |
Weakened virus. |
|
STORAGE
(in Celsius) |
-60 to -80 |
-20 |
2 to 8 |
2 to 8 |
|
EFFICACY
DATA |
95% |
95% |
62% in first dose followed by second dose. 90% in first half dose followed by second dose. |
Not available. |
|
STATUS
IN INDIA |
N/A |
N/A |
Approved. |
Approved.(In clinical trial mode) |
|
PRICING (per
dose) |
$20 |
$15-$17 |
$5-$6 |
N/A |
Not just the efficacy data, one more thing which
has the most important aspect is the “side-effects”. You must have already
heard about the normal side effects like fever, joint pain, weakness, etc. I am
talking about the serious ones.
The two from the western
world, even after completing their phase 3 trails, doesn’t really proved out to
be safe for everyone. The Pfizer shot is not recommended for the people having
history of allergic reactions. Recently, a Portuguese health worker died after
two days of vaccination, without having any adverse effects. In Mexico, a death
occurred with difficulty in breathing, seizures and skin rashes.
The thing is when the tested
vaccines are already raising questions, then are we in any position to approve
the ones in “clinical trial mode”.
This comment has been removed by the author.
ReplyDelete👌👌👌
ReplyDelete👍👍👍
ReplyDelete